Acute neurotoxicity as a serious adverse event related to rasburicase in a non-Hodgkin's lymphoma patient [4]

Annals of Oncology

Volumn 15, Issue 9, 2004, Pages 1446-

  Pitini, V ^a   Bramanti, P ^a   Arrigo, C ^a   Sessa, E ^a   La Gattuta, G ^a   Amata, C ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; DIPHENHYDRAMINE; RASBURICASE; SODIUM CHANNEL; URIC ACID;

ADULT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DRUG INFUSION; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; HUMAN; HYPERURICEMIA; LABORATORY TEST; LETTER; MYOCLONUS; NEUROTOXICITY; NONHODGKIN LYMPHOMA; PATHOGENESIS; PATIENT REFERRAL; PRIORITY JOURNAL; RESTLESSNESS; SPASTICITY; TUMOR LYSIS SYNDROME;

ACUTE DISEASE; ADULT; APHONIA; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; NEUROTOXICITY SYNDROMES; PSYCHOMOTOR AGITATION; URATE OXIDASE;

EID: 4644335084     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh362     Document Type: Letter

References (5)

1. Altman A. Acute tumor lysis syndrome. Semin Oncol 2001; 28: 3-8.
2. Coiffier B, Mounier N, Bologna S et al. Efficacy and safety of Rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during indution chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Group d'Etude des Lymphomas de l'Adulte trial) on Rasburicase activity in adult lymphoma study. J Clin Oncol 2003; 21: 1-5.
3. Ptacek L. Channelopathies: episodic disorders of the nervous system. Novartis Found Symp 2002; 241: 87-104.
4. Waxman SG. Acquired channelopathies in nerve inury and MS. Neurology 2001; 56: 1621-1627.
5. +-ATPase activity in rat striatum by metabolites accumulated in Lesch-Nyan disease. Int J Dev Neurosci 2004; 22: 11-17.